Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

Clinical trial NCT00422656 · COMPLETED

Trial details

NCT number: NCT00422656
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom's Macroglobulinemia

Start date: 2006-09-01
Primary completion: 2009-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.